丙磺舒: 一种OAT1抑制剂药物,由Merck Sharp & Dohme Corp. (Merck Sharp & Dohme Corp.)公司最早进行研发,目前全球最高研发状态为批准上市,作用机制: OAT1抑制剂(solute carrier family 22 member 6 inhibitors),治疗领域: 免疫系统疾病,遗传病与畸形,内分泌与代谢疾病
General and administrative (G&A) expenses were $7.2 million for the first quarter ended March 31, 2024, as compared to $8.3 million for the same period in 2023, reflecting reductions of full time G&A employees made in 2023. Total operating expenses were $17.6 million for the first quarter en...
The condensed financial information is prepared in accordance with IFRS, where the Group's share of its joint venture is shown as a single line item on the income statement and balance sheet and its subsidiaries including any non-controlling interest are fully consolidated. The Group uses alternati...
Photongravitational massquantum massgravitational effect of lightgeneral relativitygravitational redshiftGeneral relativity (GR) is an important theory that requires... DC Chang - 《Modern Physics Letters B Condensed Matter Physics Statistical Physics Applied Physics》 被引量: 0发表: 2022年 A Search in...
(see "About Forward-Looking Information") about future periods. This earnings release should be read in conjunction with our Second Quarter 2024 Interim Condensed Consolidated Financial Statements (Second Quarter 2024 Interim Financial Statements) and notes thereto, which have been prepared in accordance...